Actively Recruiting
Real-world Clinical Outcomes of NSCLC Patients Receiving Neoadjuvant Immunotherapy
Led by Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Updated on 2024-07-03
4000
Participants Needed
1
Research Sites
565 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to evaluate the efficacy and long-term clinical outcomes of different neoadjuvant immunotherapies in non-small cell lung cancer (NSCLC) patients using the real-world data. The main questions it aims to answer are: * What the best setting for immune checkpoint inhibitors as the neoadjuvant treatment? * How to determine the subgroups of patients benefit from neoadjuvant immunotherapy? Participants will receive neoadjuvant immunotherapy the study will analyze the real-world data.
CONDITIONS
Official Title
Real-world Clinical Outcomes of NSCLC Patients Receiving Neoadjuvant Immunotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histological diagnosis of non-small cell lung cancer (Stage I-IV, International Association for the Study of Lung Cancer staging eighth edition)
- Patients who have previously undergone immune checkpoint inhibitors as the neoadjuvant treatment
- No previous history of malignant tumors and other malignant tumors at the same time, without any anti-tumor treatment
- Eastern Cooperative Oncology Group (ECOG) score 0-1, heart, lung, liver, brain and kidney function can tolerate surgery
- At least one measurable lesion (RECIST v1.1)
You will not qualify if you...
- Patients included in unblinded clinical trials or anti-tumor drug intervention
- Radiotherapy or systemic therapy were used for NSCLC patients before the surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shugeng Gao
Beijing, Beijing Municipality, China, 100020
Actively Recruiting
Research Team
S
Shugeng Gao, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here